Page 7 - GPD-2-2
P. 7

Gene & Protein in Disease





                                        REVIEW ARTICLE
                                        Basic and clinical insights of Mu (µ)-opioid

                                        receptor in cancer



                                                    1†
                                        Ruidong Ding , Yiming Zhao , Jia Li , Siyuan Zhao , Dingyuan Su ,
                                                                 1†
                                                                                                  1
                                                                                     1
                                                                        1†
                                                 2
                                        Yue Zhang , Jia-Yi Wang , Shuangyu Lv *, and Xinying Ji *
                                                             3
                                                                                         1
                                                                          1
                                        1 Institute of Molecular Medicine, Henan International Joint Laboratory for Nuclear Protein Regulation,
                                        School of Basic Medical Sciences, Henan University, Kaifeng, Henan 475004, China
                                        2 Department of Obstetrics and Gynecology, 988 Hospital of PLA, Zhengzhou, Henan 450000, China
                                        3 San-Quan College, Xinxiang Medical University, Xinxiang, Henan 453003, China
                                        Abstract
                                        Cancer is a public health problem that is extremely harmful to people’s health.
                                        Most cancer patients experience severe pain in the advanced stage, which will
                                        seriously affect their prognosis. At present, opioids, such as morphine, have been
                                        used as the drug of choice for treating moderate to severe cancer-related pain.
                                        Mu (µ)-opioid receptor (MOR) is expressed in many different cancer cells. In this
                                        article, we present the relationship between MOR and tumor pathophysiology;
                                        summarize the molecular mechanism and effect of MOR on tumor proliferation
                                        and progression, tumor angiogenesis, tumor immunity, and cancer therapy; and
                                        propose the future research direction of MOR for cancer treatment. MOR could
            † These authors have contributed   be as a promising prognostic biomarker and immune checkpoint in cancer
            equally to this work.       therapy.
            *Corresponding authors:
            Shuangyu Lv
            (shuangyulv@163.com)        Keywords: Opioids; Mu-opioid receptor; Cancer; Angiogenesis; Immunotherapy
            Xinying Ji
            (10190096@vip.henu.edu.cn)
            Citation: Ding R, Zhao Y, Li J,
            et al., 2023, Basic and clinical   1. Introduction
            insights of Mu (µ)-opioid receptor in
            cancer. Gene Protein Dis, 2(2):282.   Cancer is one of the biggest public health problems in the world that endangers
            https://doi.org/10.36922/gpd.282
                                        human health. In 2020, the number of cancer cases worldwide was 19,292,789, and
            Received: December 1, 2022  the number of deaths was 9,958,133, according to the Global Cancer Observatory
            Accepted: March 13, 2023    (GLOBOCAN)  [1,2] . Among the different types of cancer, lung cancer, colorectal
                                        cancer (CRC), stomach cancer, liver cancer (LC), and breast cancer (BC) have the
            Published Online: March 29, 2023
                                        highest detection rates . However, the methods used in cancer treatment, such as
                                                           [3]
            Copyright: © 2023 Author(s).   surgery, chemotherapy, and radiotherapy, have not been able to completely cure the
            This is an Open-Access article
            distributed under the terms of the   tumor. Therefore, it is an urgent matter for researchers to explore efficient methods
            Creative Commons Attribution   that can be used to treat cancer. This requires a comprehensive understanding of
            License, permitting distribution, and
            reproduction in any medium, which   the pathophysiological process of tumor occurrence and development  in vivo. The
            provided that the original work is   imbalance of epigenetic mechanisms is thought to play a key role in the occurrence
            properly cited.             and  development  of  tumors [4,5] .  In  addition  to  the  epigenetic  imbalance  of  classic
            Publisher’s Note: AccScience   proto-oncogenes and tumor suppressor genes, there is new evidence that tissue-
            Publishing remains neutral with   specific genes may also be targets for cancer epigenetic disorders [6-9] . The balance
            regard to jurisdictional claims in
            published maps and institutional   between pro-angiogenic factors and anti-angiogenic factors has a significant impact
            affiliations.               on tumorigenesis [10,11] .


            Volume 2 Issue 2 (2023)                         1                         https://doi.org/10.36922/gpd.282
   2   3   4   5   6   7   8   9   10   11   12